ARTICLE | Top Story
CeNeS ends opiate deal with BGP
October 30, 2001 8:00 AM UTC
CeNeS (LSE:CEN) said it terminated a 2000 development and licensing deal with Bioglan (LSE:BGP) to develop a sublingual opiate spray product to treat breakthrough cancer pain and pain following surger...